Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 15.36B |
| Enterprise Value | 16.8B |
| P/E Ratio | -10.42 |
| PEG Ratio | -0.51 |
| Price/Sales Ratio | 11 |
| Price/Book Ratio | 11.81 |
| Enterprise/Revenue | 12.29 |
| Enterprise/EBITDA | -13.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -1.08 |
| Operating Margin | -0.97 |
| Return On Assets | -0.18 |
| Return On Equity | -1.8 |
| Revenue | 662.52M |
| Revenue/Share | 2.04 |
| Gross Profit | 662.52M |
| EBITDA | -860.38M |
| Net Income | -970.18M |
| Diluted EPS | -2.43 |
| Total Cash | 2.29B |
| Total Cash/Share | 5.35 |
| Total Debt | 3.35B |
| Total Debt/Equity | 3.84 |
| Current Ratio | 1.25 |
| Book Value Per Share | 2.52 |
| 52-Week Change | -52.47 |
| 52-Week High | 58.03 |
| 52-Week Low | 23.92 |
| Moving Average 50 Days | 30.66 |
| Moving Average 200 Days | 34.45 |
| Average Volume | 10.72M |
| Shares Outstanding | 399.6M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.05 |
| Last Split Factor | N/A |
| Last Split Date | N/A |